Sativex, Octopus 'mega-trial', Ocrevus, and Snuff: MS News Update.
Sativex, an oral cannabinoid spray, has received good patient reviews for easing MS spasticity. The world's first "mega-trial," Octopus, is recruiting participants in the UK to test several experimental MS therapies against a shared control group at the same time. Prior treatments for MS could impact the success of Ocrevus therapy. Quitting smoking or switching to snuff may help slow MS progression, but snuff is associated with many health problems.
